Method of inactivating HTLV-III virus in blood

Details Method of inactivating HTLV-III virus in blood Method of inactivating HTLV-III virus in blood

1987-10-07

1989-05-23

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Aldehyde doai

514696, 514731, 422 28, 422 36, A61K 31115, A61K 3105

Patent

active

048331651

ABSTRACT:
HTLV-III virus in blood or blood components is inactivated by treatment with about 0.1-5% of phenol, formaldehyde, or mixtures thereof, at a temperature of about 2.degree.-40.degree. C. for at least about 5 minutes.

REFERENCES:
patent: 3973913 (1976-08-01), Louderback
patent: 4675159 (1987-06-01), Al-Sioufi
Remington's Pharmaceutical Sciences, 16th Ed., 1980, pp. 1110, 1262-1263 and 1329-1330.
American Hospital Formulary Service 86, pp. 1697-1703.
AMA Drug Evaluations, 5th Ed., 1983, pp. 1399, 1404, 1411 and 1413.
The Merck Index, 10th Ed., 1983, cite #4120 and 7115.

Affiliated with

Also associated with

Rating

Method of inactivating HTLV-III virus in blood does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inactivating HTLV-III virus in blood, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inactivating HTLV-III virus in blood will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1731062